GLP-1s: Seizing Opportunity in a New CPG Landscape leads you through a detailed exploration of the GLP-1 user journey, delivering a consumer-centric understanding of the attitudinal, behavioral, commercial and cultural disruption emerging from GLP-1 adoption
If you're planning to use pre-tax health account funds, verify eligibility with your HSA/FSA administrator before enrolling
Weight loss and joint relief Excess weight creates significant mechanical stress on joints for individuals with osteoarthritis
Your healthcare team will typically schedule reviews to assess your response, check for adverse effects, and adjust your dose accordingly
The upper arm profile becomes more defined, especially for people who combine GLP-1 therapy with resistance training
All licensed GLP-1 receptor agonists are administered either as subcutaneous injections or, in limited cases, as oral tablets (such as oral semaglutide, marketed as Rybelsus)